{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:13:47Z","timestamp":1793726027573,"version":"4.6.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T00:00:00Z","timestamp":1693612800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T00:00:00Z","timestamp":1693612800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Drug-resistant\n                    <jats:italic>Neisseria gonorrhoeae<\/jats:italic>\n                    represents a major threat to public health; without new effective antibiotics, untreatable gonococcal infections loom as a real possibility. In a previous drug-repurposing study, we reported that salicylic acid had good potency against azithromycin-resistant\n                    <jats:italic>N. gonorrhoeae<\/jats:italic>\n                    . We now report that the anti-gonococcal activity in this scaffold is easily lost by inopportune substitution, but that select substituted naphthyl analogs (\n                    <jats:bold>3b<\/jats:bold>\n                    ,\n                    <jats:bold>3o<\/jats:bold>\n                    and\n                    <jats:bold>3p<\/jats:bold>\n                    ) have superior activity to salicylic acid itself. Furthermore, these compounds retained potency against multiple ceftriaxone- and azithromycin-resistant strains, exhibited rapid bactericidal activity against\n                    <jats:italic>N. gonorrhoeae<\/jats:italic>\n                    , and showed high tolerability to mammalian cells (CC\n                    <jats:sub>50<\/jats:sub>\n                    \u2009&gt;\u2009128\u00a0\u00b5g\/mL). Promisingly, these compounds also show very weak growth inhibition of commensal vaginal bacteria.\n                  <\/jats:p>","DOI":"10.1038\/s41598-023-41442-5","type":"journal-article","created":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T10:01:35Z","timestamp":1693648895000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Substituted salicylic acid analogs offer improved potency against multidrug-resistant Neisseria gonorrhoeae and good selectivity against commensal vaginal bacteria"],"prefix":"10.1038","volume":"13","author":[{"given":"Hanan","family":"Almolhim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed E. M.","family":"Elhassanny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nader S.","family":"Abutaleb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdallah S.","family":"Abdelsattar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed N.","family":"Seleem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul R.","family":"Carlier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,2]]},"reference":[{"key":"41442_CR1","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","volume":"18","author":"E Tacconelli","year":"2018","unstructured":"Tacconelli, E. et al. Discovery, research, and development of new antibiotics: The WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect. Dis. 18, 318\u2013327 (2018).","journal-title":"Lancet Infect. Dis."},{"key":"41442_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13756-020-00805-7","volume":"9","author":"A Derbie","year":"2020","unstructured":"Derbie, A., Mekonnen, D., Woldeamanuel, Y. & Abebe, T. Azithromycin resistant gonococci: A literature review. Antimicrob. Resist. Infect. Control 9, 1\u20137 (2020).","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"41442_CR3","doi-asserted-by":"publisher","first-page":"e154","DOI":"10.1016\/S2666-5247(20)30059-8","volume":"1","author":"KM Gernert","year":"2020","unstructured":"Gernert, K. M. et al. Azithromycin susceptibility of Neisseria gonorrhoeae in the USA in 2017: A genomic analysis of surveillance data. The Lancet Microbe 1, e154\u2013e164 (2020).","journal-title":"The Lancet Microbe"},{"key":"41442_CR4","doi-asserted-by":"crossref","unstructured":"Cyr, S. S. et al. CDC STI Gonorrhea Treatment Guidelines. 69, 1911\u20131916 (2020).","DOI":"10.15585\/mmwr.mm6950a6"},{"key":"41442_CR5","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.2217\/fmb.12.117","volume":"7","author":"M Unemo","year":"2012","unstructured":"Unemo, M. & Nicholas, R. A. Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea. Fut. Microbiol. 7, 1401\u20131422 (2012).","journal-title":"Fut. Microbiol."},{"key":"41442_CR6","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1128\/AAC.05760-11","volume":"56","author":"M Unemo","year":"2012","unstructured":"Unemo, M. et al. High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: Novel penA mosaic allele in a successful international clone causes treatment failure. Antimicrob. Agents Chemother. 56, 1273\u20131280 (2012).","journal-title":"Antimicrob. Agents Chemother."},{"key":"41442_CR7","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.15585\/mmwr.mm6949a5","volume":"69","author":"MA Picker","year":"2020","unstructured":"Picker, M. A. et al. Notes from the field: First case in the united states of neisseria gonorrhoeae harboring emerging mosaic penA 60 Allele, conferring reduced susceptibility to cefixime and ceftriaxone. MMWR. Morb. Mortal. Wkly. Rep. 69, 1876\u20131877 (2020).","journal-title":"MMWR. Morb. Mortal. Wkly. Rep."},{"key":"41442_CR8","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1056\/NEJMp1112456","volume":"366","author":"GA Bolan","year":"2012","unstructured":"Bolan, G. A., Sparling, P. F. & Wasserheit, J. N. The emerging threat of untreatable gonococcal infection. N. Engl. J. Med. 366, 485\u2013487 (2012).","journal-title":"N. Engl. J. Med."},{"key":"41442_CR9","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1093\/jac\/dkr261","volume":"66","author":"R Wise","year":"2011","unstructured":"Wise, R. et al. The urgent need for new antibacterial agents. J. Antimicrob. Chemother. 66, 1939\u20131940 (2011).","journal-title":"J. Antimicrob. Chemother."},{"key":"41442_CR10","doi-asserted-by":"publisher","first-page":"e0199710","DOI":"10.1371\/journal.pone.0199710","volume":"13","author":"A AbdelKhalek","year":"2018","unstructured":"AbdelKhalek, A., Abutaleb, N. S., Mohammad, H. & Seleem, M. N. Repurposing ebselen for decolonization of vancomycin-resistant enterococci (VRE). PLoS ONE 13, e0199710 (2018).","journal-title":"PLoS ONE"},{"key":"41442_CR11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1080\/14756366.2021.1991336","volume":"37","author":"NS Abutaleb","year":"2022","unstructured":"Abutaleb, N. S. et al. Repurposing FDA-approved sulphonamide carbonic anhydrase inhibitors for treatment of Neisseria gonorrhoeae. J. Enzyme Inhib. Med. Chem. 37, 51\u201361 (2022).","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"41442_CR12","doi-asserted-by":"publisher","first-page":"105454","DOI":"10.1016\/j.micpath.2022.105454","volume":"164","author":"NS Abutaleb","year":"2022","unstructured":"Abutaleb, N. S., Elhassanny, A. E. M. & Seleem, M. N. In vivo efficacy of acetazolamide in a mouse model of Neisseria gonorrhoeae infection. Microb. Pathog. 164, 105454 (2022).","journal-title":"Microb. Pathog."},{"key":"41442_CR13","doi-asserted-by":"publisher","first-page":"e0266764","DOI":"10.1371\/journal.pone.0266764","volume":"17","author":"AEM Elhassanny","year":"2022","unstructured":"Elhassanny, A. E. M., Abutaleb, N. S. & Seleem, M. N. Auranofin exerts antibacterial activity against Neisseria gonorrhoeae in a female mouse model of genital tract infection. PLoS ONE 17, e0266764 (2022).","journal-title":"PLoS ONE"},{"key":"41442_CR14","doi-asserted-by":"publisher","first-page":"10935","DOI":"10.1038\/s41598-021-90360-x","volume":"11","author":"H Mohammad","year":"2021","unstructured":"Mohammad, H., Abutaleb, N. S., Dieterly, A. M., Lyle, L. T. & Seleem, M. N. Investigating auranofin for the treatment of infected diabetic pressure ulcers in mice and dermal toxicity in pigs. Sci. Rep. 11, 10935 (2021).","journal-title":"Sci. Rep."},{"key":"41442_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0247508","volume":"16","author":"H Mohammad","year":"2021","unstructured":"Mohammad, H., Abutaleb, N. S., Dieterly, A. M., Lyle, L. T. & Seleem, M. N. Evaluation of ebselen in resolving a methicillin-resistant Staphylococcus aureus infection of pressure ulcers in obese and diabetic mice. PLoS ONE 16, 1\u201316 (2021).","journal-title":"PLoS ONE"},{"key":"41442_CR16","doi-asserted-by":"publisher","first-page":"e02115","DOI":"10.1128\/AAC.02115-19","volume":"64","author":"NS Abutaleb","year":"2020","unstructured":"Abutaleb, N. S. & Seleem, M. N. Repurposing the antiamoebic drug diiodohydroxyquinoline for treatment of clostridioides difficile infections. Antimicrob. Agents Chemother. 64, e02115-e2119 (2020).","journal-title":"Antimicrob. Agents Chemother."},{"key":"41442_CR17","doi-asserted-by":"publisher","first-page":"105828","DOI":"10.1016\/j.ijantimicag.2019.10.009","volume":"55","author":"NS Abutaleb","year":"2020","unstructured":"Abutaleb, N. S. & Seleem, M. N. Antivirulence activity of auranofin against vancomycin-resistant enterococci: In vitro and in vivo studies. Int. J. Antimicrob. Agents 55, 105828 (2020).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"41442_CR18","doi-asserted-by":"publisher","first-page":"e11059","DOI":"10.7717\/peerj.11059","volume":"9","author":"NS Abutaleb","year":"2021","unstructured":"Abutaleb, N. S., Elhassanny, A. E. M., Flaherty, D. P. & Seleem, M. N. In vitro and in vivo activities of the carbonic anhydrase inhibitor, dorzolamide, against vancomycin-resistant enterococci. PeerJ 9, e11059 (2021).","journal-title":"PeerJ"},{"key":"41442_CR19","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01715-20","author":"NS Abutaleb","year":"2021","unstructured":"Abutaleb, N. S., Elkashif, A., Flaherty, D. P. & Seleem, M. N. In vivo antibacterial activity of acetazolamide. Antimicrob. Agents Chemother. https:\/\/doi.org\/10.1128\/AAC.01715-20 (2021).","journal-title":"Antimicrob. Agents Chemother."},{"key":"41442_CR20","unstructured":"Brunton, L. L., Hilal-Dandan, R. & Knollmann, B. C. Preface. in Goodman & Gilman\u2019s: The Pharmacological Basis of Therapeutics, 13e (McGraw-Hill Education, 2017)."},{"key":"41442_CR21","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1128\/am.10.4.348-353.1962","volume":"10","author":"H Gershon","year":"1962","unstructured":"Gershon, H. & Parmegiani, R. Antimicrobial activity of 8-quinolinols, salicylic acids, hydroxynaphthoic acids, and salts of selected quinolinols with selected hydroxy-acids. Appl. Microbiol. 10, 348\u2013353 (1962).","journal-title":"Appl. Microbiol."},{"key":"41442_CR22","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/0016-5085(87)90253-8","volume":"93","author":"S Meyers","year":"1987","unstructured":"Meyers, S., Sachar, D. B., Present, D. H. & Janowitz, H. D. Olsalazine sodium in the treatment of ulcerative colitis among patients intolerant of sulfasalazine: A prospective, randomized placebo-controlled, double-blind, dose-ranging clinical trial. Gastroenterology 93, 1255\u20131262 (1987).","journal-title":"Gastroenterology"},{"key":"41442_CR23","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1097\/00000441-187510000-00010","volume":"69","author":"GH Boyland","year":"1875","unstructured":"Boyland, G. H. On the treatment of venereal disease by salicylic acid, with eight illustrative cases. Am. J. Med. Sci. 69, 413\u2013415 (1875).","journal-title":"Am. J. Med. Sci."},{"key":"41442_CR24","doi-asserted-by":"publisher","first-page":"e01225","DOI":"10.1128\/AAC.01225-19","volume":"63","author":"M Alhashimi","year":"2019","unstructured":"Alhashimi, M., Mayhoub, A. & Seleem, M. N. Repurposing salicylamide for combating multidrug-resistant neisseria gonorrhoeae. Antimicrob. Agents Chemother. 63, e01225-e1319 (2019).","journal-title":"Antimicrob. Agents Chemother."},{"key":"41442_CR25","first-page":"4","volume":"2","author":"J Ruud","year":"2010","unstructured":"Ruud, J. United States Patent\u202f: 3871965 United States Patent\u202f: 3871965. Yeast 2, 4\u20136 (2010).","journal-title":"Yeast"},{"key":"41442_CR26","doi-asserted-by":"publisher","first-page":"9468","DOI":"10.1039\/c2cc34944b","volume":"48","author":"X Feng","year":"2012","unstructured":"Feng, X. et al. Copper-catalyzed conversion of aryl and heteroaryl bromides into the corresponding chlorides. Chem. Commun. 48, 9468\u20139470 (2012).","journal-title":"Chem. Commun."},{"key":"41442_CR27","doi-asserted-by":"publisher","first-page":"4033","DOI":"10.1021\/acscatal.8b00327","volume":"8","author":"X Xiong","year":"2018","unstructured":"Xiong, X. & Yeung, Y. Y. Ammonium salt-catalyzed highly practical ortho-selective monohalogenation and phenylselenation of phenols: Scope and applications. ACS Catal. 8, 4033\u20134043 (2018).","journal-title":"ACS Catal."},{"key":"41442_CR28","doi-asserted-by":"publisher","first-page":"10856","DOI":"10.1021\/jacs.0c04427","volume":"142","author":"SE Motika","year":"2020","unstructured":"Motika, S. E. et al. Gram-Negative Antibiotic Active through Inhibition of an Essential Riboswitch. J. Am. Chem. Soc. 142, 10856\u201310862 (2020).","journal-title":"J. Am. Chem. Soc."},{"key":"41442_CR29","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/nature22308","volume":"545","author":"MF Richter","year":"2017","unstructured":"Richter, M. F. et al. Predictive compound accumulation rules yield a broad-spectrum antibiotic. Nature 545, 299\u2013304 (2017).","journal-title":"Nature"},{"key":"41442_CR30","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1016\/j.bmc.2017.01.016","volume":"25","author":"G Paraskevopoulos","year":"2017","unstructured":"Paraskevopoulos, G. et al. Novel salicylanilides from 4,5-dihalogenated salicylic acids: Synthesis, antimicrobial activity and cytotoxicity. Bioorganic Med. Chem. 25, 1524\u20131532 (2017).","journal-title":"Bioorganic Med. Chem."},{"key":"41442_CR31","doi-asserted-by":"publisher","first-page":"3096","DOI":"10.1093\/jac\/dkw288","volume":"71","author":"M Unemo","year":"2016","unstructured":"Unemo, M. et al. The novel 2016 WHO Neisseria gonorrhoeae reference strains for global quality assurance of laboratory investigations: Phenotypic, genetic and reference genome characterization. J. Antimicrob. Chemother. 71, 3096\u20133108 (2016).","journal-title":"J. Antimicrob. Chemother."},{"key":"41442_CR32","unstructured":"Centers for Disease Control and Prevention. Agar Dilution Antimicrobial Susceptibility Testing. https:\/\/www.cdc.gov\/std\/gonorrhea\/lab\/agar.htm"},{"key":"41442_CR33","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3201\/eid0901.020172","volume":"9","author":"CW Stratton","year":"2003","unstructured":"Stratton, C. W. Dead bugs don\u2019t mutate: Susceptibility issues in the emergence of bacterial resistance. Emerg. Infect. Dis. 9, 10\u201316 (2003).","journal-title":"Emerg. Infect. Dis."},{"key":"41442_CR34","doi-asserted-by":"publisher","first-page":"29707","DOI":"10.1038\/srep29707","volume":"6","author":"MF Mohamed","year":"2016","unstructured":"Mohamed, M. F., Abdelkhalek, A. & Seleem, M. N. Evaluation of short synthetic antimicrobial peptides for treatment of drug-resistant and intracellular Staphylococcus aureus. Sci. Rep. 6, 29707 (2016).","journal-title":"Sci. Rep."},{"key":"41442_CR35","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00826-18","author":"JD Lenz","year":"2018","unstructured":"Lenz, J. D., Shirk, K. A., Jolicoeur, A. & Dillard, J. P. Selective inhibition of neisseria gonorrhoeae by a dithiazoline in mixed infections with lactobacillus gasseri. Antimicrob. Agents Chemother. https:\/\/doi.org\/10.1128\/AAC.00826-18 (2018).","journal-title":"Antimicrob. Agents Chemother."},{"key":"41442_CR36","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1097\/AOG.0000000000001932","volume":"129","author":"FMT Lewis","year":"2017","unstructured":"Lewis, F. M. T., Bernstein, K. T. & Aral, S. O. Vaginal microbiome and its relationship to behavior, sexual health, and sexually transmitted diseases. Obstet. Gynecol. 129, 643\u2013654 (2017).","journal-title":"Obstet. Gynecol."},{"key":"41442_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fcimb.2017.00502","volume":"7","author":"C Foschi","year":"2017","unstructured":"Foschi, C. et al. Vaginal lactobacilli reduce Neisseria gonorrhoeae viability through multiple strategies: An in vitro study. Front. Cell. Infect. Microbiol. 7, 1\u201310 (2017).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"41442_CR38","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02206-19","author":"YJ Seong","year":"2020","unstructured":"Seong, Y. J., Alhashimi, M., Mayhoub, A., Mohammad, H. & Seleem, M. N. Repurposing fenamic acid drugs to combat multidrug-resistant neisseria gonorrhoeae. Antimicrob. Agents Chemother. https:\/\/doi.org\/10.1128\/AAC.02206-19 (2020).","journal-title":"Antimicrob. Agents Chemother."},{"key":"41442_CR39","doi-asserted-by":"publisher","first-page":"5602","DOI":"10.1038\/s41598-020-62696-3","volume":"10","author":"A Elkashif","year":"2020","unstructured":"Elkashif, A. & Seleem, M. N. Investigation of auranofin and gold-containing analogues antibacterial activity against multidrug-resistant Neisseria gonorrhoeae. Sci. Rep. 10, 5602 (2020).","journal-title":"Sci. Rep."},{"key":"41442_CR40","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.3390\/ijms22052427","volume":"22","author":"GA Naclerio","year":"2021","unstructured":"Naclerio, G. A., Abutaleb, N. S., Alhashimi, M., Seleem, M. N. & Sintim, H. O. N-(1,3,4-Oxadiazol-2-yl)benzamides as antibacterial agents against neisseria gonorrhoeae. Int. J. Mol. Sci. 22, 2427 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"41442_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14756366.2021.1988945","volume":"37","author":"S Giovannuzzi","year":"2022","unstructured":"Giovannuzzi, S. et al. Dithiocarbamates effectively inhibit the \u03b1-carbonic anhydrase from Neisseria gonorrhoeae. J. Enzyme Inhib. Med. Chem. 37, 1\u20138 (2022).","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"41442_CR42","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1021\/acsinfecdis.1c00055","volume":"7","author":"CS Hewitt","year":"2021","unstructured":"Hewitt, C. S. et al. Structure-activity relationship studies of acetazolamide-based carbonic anhydrase inhibitors with activity against neisseria gonorrhoeae. ACS Infect. Dis. 7, 1969\u20131984 (2021).","journal-title":"ACS Infect. Dis."},{"key":"41442_CR43","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.ejmech.2018.03.044","volume":"151","author":"A Kotb","year":"2018","unstructured":"Kotb, A. et al. Phenylthiazoles with tert-Butyl side chain: Metabolically stable with anti-biofilm activity. Eur. J. Med. Chem. 151, 110\u2013120 (2018).","journal-title":"Eur. J. Med. Chem."},{"key":"41442_CR44","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.ejmech.2018.04.049","volume":"152","author":"M ElAwamy","year":"2018","unstructured":"ElAwamy, M. et al. Alkoxyphenylthiazoles with broad-spectrum activity against multidrug-resistant gram-positive bacterial pathogens. Eur. J. Med. Chem. 152, 318\u2013328 (2018).","journal-title":"Eur. J. Med. Chem."},{"key":"41442_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0258465","volume":"16","author":"M Hagras","year":"2021","unstructured":"Hagras, M. et al. Evaluation of bisphenylthiazoles as a promising class for combating multidrug-resistant fungal infections. PLoS ONE 16, 1\u201317 (2021).","journal-title":"PLoS ONE"},{"key":"41442_CR46","doi-asserted-by":"publisher","first-page":"5085","DOI":"10.3390\/molecules27165085","volume":"27","author":"CW Karanja","year":"2022","unstructured":"Karanja, C. W. et al. Isoquinoline antimicrobial agent: Activity against intracellular bacteria and effect on global bacterial proteome. Molecules 27, 5085 (2022).","journal-title":"Molecules"},{"key":"41442_CR47","doi-asserted-by":"publisher","first-page":"114204","DOI":"10.1016\/j.ejmech.2022.114204","volume":"234","author":"MM Elsebaie","year":"2022","unstructured":"Elsebaie, M. M. et al. Exploring the structure-activity relationships of diphenylurea as an antibacterial scaffold active against methicillin- and vancomycin-resistant Staphylococcus aureus. Eur. J. Med. Chem. 234, 114204 (2022).","journal-title":"Eur. J. Med. Chem."},{"key":"41442_CR48","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1002\/jhet.4570","volume":"60","author":"AM Sayed","year":"2023","unstructured":"Sayed, A. M. et al. Arylpyrazole as selective anti-enterococci; synthesis and biological evaluation of novel derivatives for their antimicrobial efficacy. J. Heterocycl. Chem. 60, 134\u2013144 (2023).","journal-title":"J. Heterocycl. Chem."},{"key":"41442_CR49","doi-asserted-by":"publisher","first-page":"11934","DOI":"10.1021\/acs.jmedchem.0c01198","volume":"63","author":"GA Naclerio","year":"2020","unstructured":"Naclerio, G. A., Abutaleb, N. S., Li, D., Seleem, M. N. & Sintim, H. O. Ultrapotent inhibitor of clostridioides difficile growth, which suppresses recurrence in vivo. J. Med. Chem. 63, 11934\u201311944 (2020).","journal-title":"J. Med. Chem."},{"key":"41442_CR50","doi-asserted-by":"publisher","first-page":"112046","DOI":"10.1016\/j.ejmech.2020.112046","volume":"189","author":"M Hagras","year":"2020","unstructured":"Hagras, M. et al. Oxadiazolylthiazoles as novel and selective antifungal agents. Eur. J. Med. Chem. 189, 112046 (2020).","journal-title":"Eur. J. Med. Chem."},{"key":"41442_CR51","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ijfoodmicro.2009.03.012","volume":"132","author":"A Kushiro","year":"2009","unstructured":"Kushiro, A. et al. Antimicrobial susceptibility testing of lactic acid bacteria and bifidobacteria by broth microdilution method and Etest. Int. J. Food Microbiol. 132, 54\u201358 (2009).","journal-title":"Int. J. Food Microbiol."},{"key":"41442_CR52","doi-asserted-by":"publisher","first-page":"9772","DOI":"10.1021\/acs.jmedchem.9b01198","volume":"62","author":"X Shao","year":"2019","unstructured":"Shao, X. et al. Chemical space exploration around thieno[3,2-d]pyrimidin-4(3H)-one Scaffold Led to a novel class of highly active clostridium difficile inhibitors. J. Med. Chem. 62, 9772\u20139791 (2019).","journal-title":"J. Med. Chem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-41442-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-41442-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-41442-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T03:08:46Z","timestamp":1700363326000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-41442-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,2]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["41442"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-41442-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2822043\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,2]]},"assertion":[{"value":"16 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14468"}}